Third, the follow-up time of enrolled CRC patients was relatively short, as 18 out of 65 PDHA1-low patients had less than 1 year of follow-up, which resulted in imperfect results of Kaplan–Meier analysis. The gene discussed is PDHA1; the disease is colorectal carcinoma.